St. Jude childhood cancer follow-up data study
Part of Cancer clinical trials.
This study collects information from children who are currently being treated or followed at St. Jude for childhood cancer. It helps researchers understand care outcomes and improve future planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a current St. Jude patient being treated or followed for childhood cancer
- You are not only a “consult” patient at St. Jude
- You are still actively in St. Jude follow-up (not permanently discharged)
- You did not come to St. Jude for limited care under a phase 1 plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people in Switzerland who finished treatment for childhood or teen cancer to learn about their long-term health. It may help doctors better understand late effects and follow-up needs after cancer treatment.
This study follows people who were treated for childhood cancer and compares them with similar adults who did not have that childhood cancer. It aims to learn about long-term health and especially walking or mobility issues over time, using check-ins that may include a mobility assessment.
This study looks at genetic (DNA) differences to better understand why treatments work differently for children at St. Jude. It may help doctors choose safer or more effective treatments in the future.
This study looks at the long-term health of people who were treated for medulloblastoma with craniospinal radiation at St. Jude Children's Research Hospital. It aims to understand how they are doing years after treatment.
This study collects and studies tissue or bone marrow samples from certain childhood tumors. The goal is to learn what’s going on inside the cancer (using molecular testing) to better understand the disease and how it may respond to treatment.
This study collects children’s normal and tumor tissue (or blood-related normal samples) and reads their DNA/RNA to look at genetic information. It may help researchers understand cancer-related changes and improve future testing, even when the goal isn’t to treat you directly.
Hear when a new Childhood Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.